Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    An NIH transition notice was added, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-25T14:04:56.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov software revision changed from v3.7.1 to v3.7.2. The study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T14:07:49.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T14:16:09.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 appears in the history, replacing the previous v3.6.6. This indicates an update to the page's revision-tracking mechanism rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-20T10:38:33.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Added revision v3.6.6 to the study's record history, reflecting an update to the page's versioning. The previous revision v3.6.5 is no longer listed in the current history.
    Difference
    0.1%
    Check dated 2026-08-30T00:00:06.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.6.5' appears in the history, while the previous 'Revision: v3.6.4' entry is removed, reflecting a backend update to the page's version history.
    Difference
    0.1%
    Check dated 2026-08-08T18:51:27.000Z thumbnail image

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.